{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:39:18Z","timestamp":1781307558090,"version":"3.54.1"},"reference-count":31,"publisher":"e-Century Publishing Corporation","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/fkmc5805","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:12:04Z","timestamp":1767075124000},"page":"5256-5265","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of combined detection of serological biomarkers in thyroid carcinoma"],"prefix":"10.62347","volume":"15","author":[{"given":"Quandong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"154371","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","volume":"243","author":"Doghish","year":"2023","unstructured":"Doghish AS, El-Mahdy HA, Ismail A, Hegazy M, Mokhtar MM, Elkhawaga SY, Elkady MA, Yehia AM and Elsakka EGE. Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways. Pathol Res Pract 2023; 243: 154371.","journal-title":"Pathol Res Pract"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/cncr.31245","article-title":"Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules","volume":"124","author":"Nikiforova","year":"2018","unstructured":"Nikiforova MN, Mercurio S, Wald AI, Barbi de Moura M, Callenberg K, Santana-Santos L, Gooding WE, Yip L, Ferris RL and Nikiforov YE. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 2018; 124: 1682-1690.","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","article-title":"Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study","volume":"25","author":"Angelis R","year":"2024","unstructured":"De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L and Rossi S; EUROCARE-6 Working Group. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol 2024; 25: 293-307.","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.3390\/biomedicines12122722","article-title":"Progressive cachexia: tuberculosis, cancer, or thyrotoxicosis? Disease-directed therapy and atypical courses of autoimmune and malignant thyroid diseases in a high specialization era: case-control study with a critical literature review","volume":"12","author":"Zdziarski","year":"2024","unstructured":"Zdziarski P and Sroka Z. Progressive cachexia: tuberculosis, cancer, or thyrotoxicosis? Disease-directed therapy and atypical courses of autoimmune and malignant thyroid diseases in a high specialization era: case-control study with a critical literature review. Biomedicines 2024; 12: 2722.","journal-title":"Biomedicines"},{"key":"ref4","unstructured":"Fu Y, Ai X, Xiao X, Yang A, Wang YH, Li WS and Li YQ. Residual capsule network based thyroid cancer ultrasonic image analyzing method, involves obtaining ultrasonic image classification identification result corresponding to thyroid papillary cancer ultrasonic image. China patent CN112233106A."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2447850","DOI":"10.1080\/08941939.2024.2447850","article-title":"Radical resection of differentiated thyroid cancer in elderly patients: evaluation of the efficacy of the immunocolloidal gold strip method combined with nanocarbon negative imaging tracing technology for parathyroid gland imaging","volume":"38","author":"Liu","year":"2025","unstructured":"Liu Y, Zuo L, Xin Y, Liu Y, Tian Z and Shang X. Radical resection of differentiated thyroid cancer in elderly patients: evaluation of the efficacy of the immunocolloidal gold strip method combined with nanocarbon negative imaging tracing technology for parathyroid gland imaging. J Invest Surg 2025; 38: 2447850.","journal-title":"J Invest Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3109\/00365521.2016.1144783","article-title":"Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer","volume":"51","author":"MH","year":"2016","unstructured":"Hvolris MH, Piper TB, Hammer E, Jørgensen LN, Olsen J, Rahr HB, Nielsen KT, Laurberg S, Christensen IJ, Brünner N, Johansen JS, Davis GJ, Dowell BL and Nielsen HJ. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer. Scand J Gastroenterol 2016; 51: 860-865.","journal-title":"Scand J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/ijc.34974","article-title":"Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort","volume":"155","author":"CM","year":"2024","unstructured":"Kitahara CM, Surcel HM, Falk R, Pfeiffer RM, Männistö T, Gissler M and Trabert B. Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort. Int J Cancer 2024; 155: 1014-1022.","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12884-023-05588-4","article-title":"Pregnancy outcomes and neonatal thyroid function in women with thyroid cancer: a retrospective study","volume":"23","author":"Yuan","year":"2023","unstructured":"Yuan X, Zhao J, Wang J, Zheng W, Kong Y and Li G. Pregnancy outcomes and neonatal thyroid function in women with thyroid cancer: a retrospective study. BMC Pregnancy Childbirth 2023; 23: 383.","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.23736\/s2724-6507.24.04207-6","article-title":"Combining TSH measurement with TIRADS assessment to further improve the detection of thyroid cancers","volume":"49","author":"Trimboli","year":"2024","unstructured":"Trimboli P, Curti M, Colombo A, Scappaticcio L and Leoncini A. Combining TSH measurement with TIRADS assessment to further improve the detection of thyroid cancers. Minerva Endocrinol (Torino) 2024; 49: 125-131.","journal-title":"Minerva Endocrinol (Torino)"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Çelik S, Uç ZA and Candan O. Do different TSH suppression levels effect heart rate variability and QT dispersions in patients with differentiated thyroid cancer? Endocr Res 2025; 50: 28-35.","DOI":"10.1080\/07435800.2024.2383669"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1372553","DOI":"10.3389\/fendo.2024.1372553","article-title":"Advances in targeted therapy and biomarker research in thyroid cancer","volume":"15","author":"Guo","year":"2024","unstructured":"Guo M, Sun Y, Wei Y, Xu J and Zhang C. Advances in targeted therapy and biomarker research in thyroid cancer. Front Endocrinol (Lausanne) 2024; 15: 1372553.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"116971","DOI":"10.1016\/j.biopha.2024.116971","article-title":"Ferroptosis in thyroid cancer: potential mechanisms, effective therapeutic targets and predictive biomarker","volume":"177","author":"Chen","year":"2024","unstructured":"Chen Y, Pan G, Wu F, Zhang Y, Li Y and Luo D. Ferroptosis in thyroid cancer: potential mechanisms, effective therapeutic targets and predictive biomarker. Biomed Pharmacother 2024; 177: 116971.","journal-title":"Biomed Pharmacother"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/2211536611666220124115445","article-title":"Identification of prognostic biomarkers in papillary thyroid cancer and developing non-invasive diagnostic models through integrated bioinformatics analysis","volume":"11","author":"AA","year":"2022","unstructured":"Oskouie AA, Ahmadi MS and Taherkhani A. Identification of prognostic biomarkers in papillary thyroid cancer and developing non-invasive diagnostic models through integrated bioinformatics analysis. Microrna 2022; 11: 73-87.","journal-title":"Microrna"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3892\/ijo.2017.4065","article-title":"Galectin-1 is a diagnostic marker involved in thyroid cancer progression","volume":"51","author":"Arcolia","year":"2017","unstructured":"Arcolia V, Journe F, Wattier A, Leteurtre E, Renaud F, Gabius HJ, Remmelink M, Decaestecker C, Rodriguez A, Boutry S, Laurent S and Saussez S. Galectin-1 is a diagnostic marker involved in thyroid cancer progression. Int J Oncol 2017; 51: 760-770.","journal-title":"Int J Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3892\/ol.2024.14643","article-title":"FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis","volume":"28","author":"Pan","year":"2024","unstructured":"Pan H, Luo Z, Lin F, Zhang J, Xiong T, Hong Y, Sun B and Yang Y. FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis. Oncol Lett 2024; 28: 510.","journal-title":"Oncol Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.3390\/jcm13185396","article-title":"detection of the BRAFV600E mutation in circulating free nucleic acids as a biomarker of thyroid cancer: a review","volume":"13","author":"Niedziela","year":"2024","unstructured":"Niedziela E, Niedziela Ł, Kowalska A and Kowalik A. detection of the BRAFV600E mutation in circulating free nucleic acids as a biomarker of thyroid cancer: a review. J Clin Med 2024; 13: 5396.","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archoto.2011.186","article-title":"Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease","volume":"137","author":"Darr","year":"2011","unstructured":"Darr EA, Patel AD, Yu G, Komorowski Z, McCormick S, Tiwari R, Schantz SP and Geliebter J. Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease. Arch Otolaryngol Head Neck Surg 2011; 137: 1161-1165.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref18","unstructured":"Puglisi F, Cesselli D, Damante G, Pellizzari L, Beltrami CA and Di Loreto C. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases. Anticancer Res 2000; 20(1A): 311-316."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/thy.1999.9.455","article-title":"Analysis of human sodium\/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases","volume":"9","author":"Joba","year":"1999","unstructured":"Joba W, Spitzweg C, Schriever K and Heufelder AE. Analysis of human sodium\/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases. Thyroid 1999; 9: 455-466.","journal-title":"Thyroid"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/jama.1979.03290350043022","article-title":"Thyroglobulin in benign and malignant thyroid disease","volume":"241","author":"Gerfo","year":"1979","unstructured":"Gerfo PL, Colacchio T, Colacchio D and Feind C. Thyroglobulin in benign and malignant thyroid disease. JAMA 1979; 241: 923-924.","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1590\/2359-3997000000103","article-title":"Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases","volume":"60","author":"Xavier","year":"2016","unstructured":"Xavier AC, Maciel RM, Vieira JG, Dias-da-Silva MR and Martins JR. Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases. Arch Endocrinol Metab 2016; 60: 66-75.","journal-title":"Arch Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s12020-023-03658-3","article-title":"Clinical use of thyroglobulin: not only thyroid cancer","volume":"84","author":"Berli&#x144","year":"2024","unstructured":"Berlińska A and Świątkowska-Stodulska R. Clinical use of thyroglobulin: not only thyroid cancer. Endocrine 2024; 84: 786-799.","journal-title":"Endocrine"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.3390\/jcm13092463","article-title":"Diagnostic, theranostic and prognostic value of thyroglobulin in thyroid cancer","volume":"13","author":"Giovanella","year":"2024","unstructured":"Giovanella L, D’Aurizio F, Petranović Ovčariček P and Görges R. Diagnostic, theranostic and prognostic value of thyroglobulin in thyroid cancer. J Clin Med 2024; 13: 2463.","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1055\/a-2278-6549","article-title":"Thyroglobulin antibodies and tumor epitope-specific cellular immunity in papillary thyroid cancer","volume":"56","author":"Allelein","year":"2024","unstructured":"Allelein S, Ehlers M, Thoma T, Mattes-György K, Antke C, Mamlins E, Muchalla M, Giesel F and Schott M. Thyroglobulin antibodies and tumor epitope-specific cellular immunity in papillary thyroid cancer. Horm Metab Res 2024; 56: 424-428.","journal-title":"Horm Metab Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.7150\/jca.101395","article-title":"New horizons of biomarkers in metastatic thyroid cancer","volume":"16","author":"AS","year":"2025","unstructured":"Cendra AS, Pekarek L, Pedrejón BI, Bernier L, Cervantes EDR, Cendra CS, Cassinello J, López-Gonzalez L, Mañez F, Carrero CB, Fernández CT, Giménez TR, García DMC, Gutiérrez-Calvo A, Álvarez-Mon M, Díaz-Pedrero R and Ortega MA. New horizons of biomarkers in metastatic thyroid cancer. J Cancer 2025; 16: 241-264.","journal-title":"J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.3390\/ijms25126719","article-title":"Biomarkers in thyroid cancer: emerging opportunities from non-coding RNAS and mitochondrial space","volume":"25","author":"Caban&#xE9","year":"2024","unstructured":"Cabané P, Correa C, Bode I, Aguilar R and Elorza AA. Biomarkers in thyroid cancer: emerging opportunities from non-coding RNAS and mitochondrial space. Int J Mol Sci 2024; 25: 6719.","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1474267","DOI":"10.3389\/fonc.2024.1474267","article-title":"The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer","volume":"14","author":"Sabi","year":"2024","unstructured":"Sabi EM. The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer. Front Oncol 2024; 14: 1474267.","journal-title":"Front Oncol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Santana NO, Freitas RMC, Marcos VN, Chammas MC, Camargo RYA, Schmerling CK, Vanderlei FAB, Hoff AO, Marui S and Danilovic DLS. Diagnostic performance of thyroid ultrasound in Hürthle cell carcinomas. Arch Endocrinol Metab 2019; 63: 300-305.","DOI":"10.20945\/2359-3997000000131"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CCO.0b013e32835a87c8","article-title":"Ultrasound elastography in the evaluation of thyroid nodules for thyroid cancer","volume":"25","author":"Carneiro-Pla","year":"2013","unstructured":"Carneiro-Pla D. Ultrasound elastography in the evaluation of thyroid nodules for thyroid cancer. Curr Opin Oncol 2013; 25: 1-5.","journal-title":"Curr Opin Oncol"},{"key":"ref30","unstructured":"Xu LI, Wen-Bo W, Tian G, Tao-Hua G and Yan Z. Lymphatic and venous contrast-enhanced ultrasound imaging for differential diagnosis of cervical lymph node metastasis in thyroid cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2025; 47: 16-22."}],"container-title":["American Journal of Cancer Research"],"original-title":[],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:12:30Z","timestamp":1768975950000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/12\/ajcr0168811.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/fkmc5805","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}